Thanks. It is worth noting a lot of traditional OTC products since 2008 crisis have moved to either electronic (exchange, ATS, MTF etc) with CLOB/RFQ/Auction style of execution and in some causes that's coupled with central clearing. A lot of this has come from regulation - DoddFrank, MiFID2 and its still on-going.
The most interesting aspect of this is that its enabled non-dealer <> non-dealer trading via certain venues.
This is a significant tailwind for the next wave of electronification that we're hoping to advance. US swap dealers, for example, now have a SEF reporting requirement, but most of the pre-trade is still in the screens. A Smart Market that allows dealers to control for non-price factors could change that.
Comments
Thanks. It is worth noting a lot of traditional OTC products since 2008 crisis have moved to either electronic (exchange, ATS, MTF etc) with CLOB/RFQ/Auction style of execution and in some causes that's coupled with central clearing. A lot of this has come from regulation - DoddFrank, MiFID2 and its still on-going.
The most interesting aspect of this is that its enabled non-dealer <> non-dealer trading via certain venues.
This is a significant tailwind for the next wave of electronification that we're hoping to advance. US swap dealers, for example, now have a SEF reporting requirement, but most of the pre-trade is still in the screens. A Smart Market that allows dealers to control for non-price factors could change that.